BiomX Inc.

03/18/2026 | Press release | Distributed by Public on 03/18/2026 15:48

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Yeganeh Reuven
2. Issuer Name and Ticker or Trading Symbol
BiomX Inc. [PHGE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4
3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026
(Street)
NESS ZIONA 414003
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.0001 par value per share 03/16/2026 C(1) 450,000 A $2(1) 450,000 I Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share 03/16/2026 S(3) 450,000 D $5(3) 0 I Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share 03/17/2026 C(1) 530,000 A $2(1) 530,000 I Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share 03/17/2026 S(3) 530,000 D $5(3) 0 I Pyu Pyu Capital LLC(2)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series Y Convertible Preferred Stock $2(1) 03/16/2026 C(1) 900 01/13/2026 01/13/2027 Common Stock 450,000 $ 0 (1) 1,060 I Pyu Pyu Capital LLC(2)
Series Y Convertible Preferred Stock $2(1) 03/17/2026 C(1) 1,060 01/13/2026 01/13/2027 Common Stock 530,000 $ 0 (1) 0 I Pyu Pyu Capital LLC(2)
Common Stock Purchase Warrants $1 03/16/2026 S(4) 1,300,000 01/13/2026 01/13/2031 Common Stock 1,300,000 $5 2,000,000 I Pyu Pyu Capital LLC(2)
Common Stock Purchase Warrants $1 03/16/2026 S(4) 2,000,000 01/13/2026 01/13/2031 Common Stock 300,000 $5.24 1,700,000 I Pyu Pyu Capital LLC(2)
Common Stock Purchase Warrants $1 03/16/2026 S(4) 1,700,000 01/13/2026 01/13/2031 Common Stock 1,700,000 $4.76 0 I Pyu Pyu Capital LLC(2)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Yeganeh Reuven
C/O BIOMX INC.
22 EINSTEIN ST., FLOOR 4
NESS ZIONA 414003
X X

Signatures

/s/ Reuven Yeganeh 03/18/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share.
(2) The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
(3) The shares of Common Stock were sold in private transactions at a price of $5.00 per share.
(4) The warrants were sold in private transactions at the specified price per warrant share.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
BiomX Inc. published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 18, 2026 at 21:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]